{
    "2020-04-24": [
        [
            {
                "time": "2018-04-24",
                "original_text": "格隆汇港股聚焦(4.24)︱龙湖13亿港元认购绿城服务股份中国太保一季度净利同比增长53%",
                "features": {
                    "keywords": [
                        "龙湖",
                        "绿城服务",
                        "中国太保",
                        "一季度",
                        "净利增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "房地产",
                        "保险"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "A股头条之上市公司（4.24）",
                "features": {
                    "keywords": [
                        "A股",
                        "上市公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "检测试剂板块再度走强一季度药企业绩分化明显|医药周报",
                "features": {
                    "keywords": [
                        "检测试剂",
                        "药企",
                        "业绩分化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "近4万股东一字闷杀！“神药”破灭，暴涨牛股“翻车”，18股资金大逃出",
                "features": {
                    "keywords": [
                        "股东",
                        "神药",
                        "暴跌",
                        "资金流出"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "北向资金净流入32.5亿元 机构1.57亿元抢筹安集科技",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流入",
                        "安集科技"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "复星医药：治非霍奇金淋巴瘤及类风湿关节炎药利妥昔单抗注射液获药品补充申请批件",
                "features": {
                    "keywords": [
                        "复星医药",
                        "利妥昔单抗",
                        "药品补充申请"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "证监会：重拳打击上市公司财务造假、欺诈等行为",
                "features": {
                    "keywords": [
                        "证监会",
                        "财务造假",
                        "欺诈"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "大规模核酸检测展开 相关上市公司受益几何",
                "features": {
                    "keywords": [
                        "核酸检测",
                        "上市公司",
                        "受益"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}